Hebias
Hebias is a company dedicated to optimizing the value of innovation in healthcare. They provide expertise in market access, health economics, data analysis, and strategy to support pharmaceutical, diagnostic, MedTech, and digital health innovations. Their mission is to guide clients from clinical study design to post-launch, ensuring successful market entry and optimal healthcare impact. Hebias emphasizes transparency, scientific rigor, and tailored solutions to help clients navigate complex healthcare markets and maximize the societal health gain of their innovations.
Industries
Nr. of Employees
small (1-50)
Products
Interactive value demonstration tools (web and mobile)
Platform-agnostic interactive tools to visualise budget impact, cost-effectiveness and scenario analyses for stakeholders.
Market access abbreviations database
Searchable database containing a curated shortlist of market access-related abbreviations to support document consistency and communication.
Launch planner and market-access toolset
Operational launch-planning tools and resources (launch planner, price lists, market access calendar, CRM agendas) to support commercial and market-access readiness.
Belgian market launches and pricing database
Client-accessible historical database of national product launches, price changes and indication metadata since 2010 to inform market intelligence and modelling.
Interactive value demonstration tools (web and mobile)
Platform-agnostic interactive tools to visualise budget impact, cost-effectiveness and scenario analyses for stakeholders.
Market access abbreviations database
Searchable database containing a curated shortlist of market access-related abbreviations to support document consistency and communication.
Launch planner and market-access toolset
Operational launch-planning tools and resources (launch planner, price lists, market access calendar, CRM agendas) to support commercial and market-access readiness.
Belgian market launches and pricing database
Client-accessible historical database of national product launches, price changes and indication metadata since 2010 to inform market intelligence and modelling.
Services
Advisory services covering strategy, pricing, reimbursement and stakeholder engagement to optimise market entry and access.
Preparation of budget impact analyses and strategic plans to anticipate payer budgets and negotiate reimbursement conditions.
Construction of economic models, ICER and NMB calculations and interpretation for reimbursement submissions and payer negotiations.
Design and execution of data collection strategies (surveys, Delphi panels, registries), deterministic and systematic literature searches, dataset validation and access to historical market data for modelling.
Design and delivery of web and mobile tools to demonstrate value propositions to stakeholders and enable interactive scenario exploration.
Advice and operational support for early access programs, temporary reimbursement and Managed Entry Agreements.
Advisory services covering strategy, pricing, reimbursement and stakeholder engagement to optimise market entry and access.
Preparation of budget impact analyses and strategic plans to anticipate payer budgets and negotiate reimbursement conditions.
Construction of economic models, ICER and NMB calculations and interpretation for reimbursement submissions and payer negotiations.
Design and execution of data collection strategies (surveys, Delphi panels, registries), deterministic and systematic literature searches, dataset validation and access to historical market data for modelling.
Design and delivery of web and mobile tools to demonstrate value propositions to stakeholders and enable interactive scenario exploration.
Advice and operational support for early access programs, temporary reimbursement and Managed Entry Agreements.
Expertise Areas
- Market access consulting (BeNeLux)
- Health economics and cost-effectiveness analysis
- Budget impact analysis and strategy
- Health-economic modelling and model validation
Key Technologies
- Health state transition modelling
- Budget impact modelling
- Cost-effectiveness analysis (ICER)
- Net Monetary Benefit (NMB) calculation
News & Updates
An analysis of the pros and cons of using a single versus hybrid economic model for health economic evaluations.
Insights into the impact of using two independent datasets in health economic analyses.
Discussion on how WTP thresholds relate to medical need and societal value in healthcare decision-making.
Exploring methods to handle uncertainty in health economic models through sensitivity analysis.
Understanding how to evaluate the worthiness of healthcare innovations using NMB.
An analysis of the pros and cons of using a single versus hybrid economic model for health economic evaluations.
Insights into the impact of using two independent datasets in health economic analyses.
Discussion on how WTP thresholds relate to medical need and societal value in healthcare decision-making.
Exploring methods to handle uncertainty in health economic models through sensitivity analysis.
Understanding how to evaluate the worthiness of healthcare innovations using NMB.